Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Witzig

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Leukemia|July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I studyG S Nowakowski, B LaPlant, T M Habermann, et al.
European Journal of Nuclear Medicine|August 22, 2000
Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphomaG A Wiseman, C A White, M Stabin, et al.
Blood Cancer Journal|June 1, 2014
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomasR Briski, A L Feldman, N G Bailey, et al.
Kidney International|April 4, 2008
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chainsN Leung, M A Gertz, S R Zeldenrust, et al.
Journal of the National Cancer Institute|August 5, 1999
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancersK C Halling, A J French, S K McDonnell, et al.
Leukemia|February 20, 2003
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelomaC S Debes-Marun, G W Dewald, S Bryant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2013
Bowel perforation in intestinal lymphoma: incidence and clinical featuresR Vaidya, T M Habermann, J H Donohue, et al.
Leukemia|January 19, 2007
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapyA K Stewart, P L Bergsagel, P R Greipp, et al.
Blood Cancer Journal|August 26, 2017
Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphomaS I Tracy, M J Maurer, T E Witzig, et al.
Bone Marrow Transplantation|September 5, 2017
A phase 1 trial of <sup>90</sup>Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myelomaA Dispenzieri, A D'Souza, M A Gertz, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Leukemia|July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I studyG S Nowakowski, B LaPlant, T M Habermann, et al.
European Journal of Nuclear Medicine|August 22, 2000
Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphomaG A Wiseman, C A White, M Stabin, et al.
Blood Cancer Journal|June 1, 2014
The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomasR Briski, A L Feldman, N G Bailey, et al.
Kidney International|April 4, 2008
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chainsN Leung, M A Gertz, S R Zeldenrust, et al.
Journal of the National Cancer Institute|August 5, 1999
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancersK C Halling, A J French, S K McDonnell, et al.
Leukemia|February 20, 2003
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelomaC S Debes-Marun, G W Dewald, S Bryant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 25, 2013
Bowel perforation in intestinal lymphoma: incidence and clinical featuresR Vaidya, T M Habermann, J H Donohue, et al.
Leukemia|January 19, 2007
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapyA K Stewart, P L Bergsagel, P R Greipp, et al.
Blood Cancer Journal|August 26, 2017
Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphomaS I Tracy, M J Maurer, T E Witzig, et al.
Bone Marrow Transplantation|September 5, 2017
A phase 1 trial of <sup>90</sup>Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myelomaA Dispenzieri, A D'Souza, M A Gertz, et al.
Pageof 17